Language matters when interacting with patients who have conditions such as long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and dysautonomia.
The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized ...
After Hiding My Undiagnosed Neurological Condition for Decades, I Finally Found Answers A personal quest and progress in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback